최선(崔善) 교수
약학과[대학원] /제약산업학과[대학원] /약학부
최선 교수는 약학대학 및 대학원 약학과 교수로서 컴퓨터를 이용한 약물설계 및 분자모델링 분야의 전문가이다. 본교 약대를 졸업하고, 미국 State University of New York at Buffalo에서 의약화학 전공으로 박사학위를 받았으며, 미국 Northwestern 대학에서 Post-doctoral Fellow를 하였다. 그후 2001년부터 2005년까지 컴퓨터를 이용한 약물설계 분야의 파이오니어적 회사인 미국 Tripos 본사에서 Molecular Modeler/Computational Chemist로 근무하며 신약개발 연구에 기여하고, 2005년부터 본교 교수로 재직 중이다. 최선 교수는 질병에 중요한 효소, GPCR, 이온채널 등을 대상으로 하는 약물설계와 신약개발을 위한 다양한 연구 프로젝트들을 진행하고 있다. 컴퓨터를 이용한 약물설계와 화학정보학 및 계산의약화학 등이 통합된 첨단 기술을 이용하여 암, 바이러스, 심혈관계 질환, 골다공증 등 다양한 질환에 대한 약물개발 전략을 세우고, 지식기반의 활성물질 검색 및 구조-활성 상관관계 분석, 활성 부위와 약리작용단 분석, 화합물 라이브러리와 신물질 설계, 도킹 등을 이용한 가상탐색, 효능예측, HTS data 분석, hit/선도물질의 최적화, 타겟 단백질과 리간드의 상호작용 및 작용기전에 대한 연구를 수행하고 있다. 또한, 단백질 다이나믹스와 알로스테리 규명을 위한 multi-scale simulation도 활발히 연구하고 있다. 최선 교수는 이러한 연구결과들을 <JACS(Journal of the American Chemical Society)>, <JMC(Journal of Medicinal Chemistry)> 등 저명한 국제학술지에 50여 편의 논문으로 발표하였고, 18th EuroQSAR Symposium 'Discovery Informatics & Drug Design'에서 Best Poster Presentation Award와 EFMC 'XXth International Symposium on Medicinal Chemistry'에서 Wiley-VCH ChemMedChem Poster Prize 등을 수상하였다. 최선 교수의 연구실은 2011년 9월부터 한국연구재단의 지원을 받아 중견연구자 도약연구과제로 '단백질 상호작용의 Hot Spot과 알로스테릭 제어기전 규명을 위한 멀티스케일 시뮬레이션 연구 및 알로스테릭 저해제 기반 연구'를 수행하고 있으며, 미래창조과학부 지정 국가선도연구실(National Leading Research Laboratory; NLRL)로서 다양한 신약개발 연구를 진행하고 있다.
- 약학관 B동 114호
- 02-3277-4503
- 면담 가능시간
- Anytime upon appointment
연구실적
- Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites Cancer Communications, 2024, v.44 no.1, 47-75
- Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway Biomaterials Research, 2023, v.27 no.1, 23
- DMAP and TBPP-mediated synthesis of urea-substituted nucleobases and nucleosides Tetrahedron, 2023, v.140, 133472
- Dynamic allosteric networks drive adenosine A1 receptor activation and G-protein coupling Biophysical journal, 2023, v.122 no.3S1
- Dynamic allosteric networks drive adenosine A1 receptor activation and G-protein coupling ELIFE, 2023, v.12, RP90773
- On the classical reaction rate and the first-time problems of Brownian motion Physica A: Statistical Mechanics and its Applications, 2023, v.622, 128823
- Structure-Activity Relationships of Truncated 1′-Homologated Carbaadenosine Derivatives as New PPARγ/δ Ligands: A Study on Sugar Puckering Affecting Binding to PPARs Journal of Medicinal Chemistry, 2023, v.66 no.7, 4961-4978
- Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD) Biochemical Society Transactions, 2022, v.50 no.1, 241-252
- CHARMM-GUI Enhanced Sampler for various collective variables and enhanced sampling methods PROTEIN SCIENCE, 2022, v.31 no.11, e4446
- Discovery of (E)-3-(3-((2-Cyano-4' -dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis JOURNAL OF MEDICINAL CHEMISTRY, 2022, v.65 no.14, 9974-10000
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A2AAdenosine Receptor Journal of Medicinal Chemistry, 2022, v.65 no.17, 11648-11657
- Total synthesis of thioamycolamide A using diastereoselective sulfa-Michael addition as the key step Organic Chemistry Frontiers, 2022
- 2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonists Bioorganic and Medicinal Chemistry Letters, 2021, v.48, 128266
- Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors JOURNAL OF MEDICINAL CHEMISTRY, 2021, v.64 no.2, 958-979
- Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity Shift Journal of Medicinal Chemistry, 2021, v.64 no.1, 370-384
- Emerging computational approaches for the study of regio- And stereoselectivity in organic synthesis Organic Chemistry Frontiers, 2021, v.8 no.18, 5165-5181
- N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application THERANOSTICS, 2021, v.11 no.16, 8092-8111
- Recent applications of deep learning methods on evolutionand contact-based protein structure prediction International Journal of Molecular Sciences, 2021, v.22 no.11, 6032
- Structural Characterization of Receptor-Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.6, 3241
- Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A(3) Adenosine Receptor Homology Models and Structural Network Analysis Can Predict This Boundary JOURNAL OF MEDICINAL CHEMISTRY, 2021, v.64 no.17, 12525-12536
- Advances in Molecular Dynamics Simulations and Enhanced Sampling Methods for the Study of Protein Systems INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.17, 6339
- Asymmetric Total Syntheses of Kopsane Alkaloids via a PtCl2-Catalyzed Intramolecular [3+2] Cycloaddition Angewandte Chemie, 2020, v.132 no.31, 12932-12936
- Asymmetric Total Syntheses of Kopsane Alkaloids via a PtCl2-Catalyzed Intramolecular [3+2] Cycloaddition Angewandte Chemie - International Edition, 2020, v.59 no.31, 12832-12836
- Multiscale Molecular Modeling in G Protein-Coupled Receptor (GPCR)-Ligand Studies BIOMOLECULES, 2020, v.10 no.4, 631
- Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design JOURNAL OF MEDICINAL CHEMISTRY, 2019, v.62 no.17, 8011-8027
- Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs) Current Opinion in Structural Biology, 2019, v.55, 147-153
- In Vivo Albumin Traps Photosensitizer Monomers from Self-Assembled Phthalocyanine Nanovesicles: A Facile and Switchable Theranostic Approach Journal of the American Chemical Society, 2019, v.141 no.3, 1366-1372
- Total Synthesis of Hoiamide A Using an Evans-Tishchenko Reaction as a Key Step Organic Letters, 2019, v.21 no.14, 5471-5474
- Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 Signaling CELL METABOLISM, 2019, v.29 no.6, 1306-
- Water-Soluble Phthalocyanines Selectively Bind to Albumin Dimers: A Green Approach Toward Enhancing Tumor-Targeted Photodynamic Therapy THERANOSTICS, 2019, v.9 no.22, 6412-6423
- 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands BIOORGANIC & MEDICINAL CHEMISTRY, 2018, v.26 no.15, 4509-4517
- Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity ACS Medicinal Chemistry Letters, 2018, v.9 no.12, 1247-1252
- Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery MOLECULES, 2018, v.23 no.8, 1963
- Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design FRONTIERS IN PHARMACOLOGY, 2018, v.9
- Inhibitory effect of tartrate against phosphate-induced DJ-1 aggregation INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, v.107, 1650-1658
- Integrated Ligand and Structure-Based Investigation of Structural Requirements for Silent Information Regulator 1 (SIRT1) Activation CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, v.18 no.27, 2313-2324
- Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region Bioorganic and Medicinal Chemistry, 2018, v.26 no.5, 1035-1049
- Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations JOURNAL OF MEDICINAL CHEMISTRY, 2018, v.61 no.1, 1-46
- Structural and Biochemical Characterization of the Curcumin-Reducing Activity of CurA from Vibrio vulnificus JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, v.66 no.40, 10608-10616
- Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors BIOORGANIC & MEDICINAL CHEMISTRY, 2018, v.26 no.12, 3133-3144
- Understanding G protein-coupled receptor allostery via molecular dynamics simulations: Implications for drug discovery Methods in Molecular Biology, 2018, v.1762, 455-472
- Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design Journal of Medicinal Chemistry, 2017, v.60 no.6, 2573-2590
- Expediting the design, discovery and development of anticancer drugs using computational approaches Current Medicinal Chemistry, 2017, v.24 no.42, 4753-4778
- In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, v.28 no.10 SI, 863-874
- MLACP: machine-learning-based prediction of anticancer peptides ONCOTARGET, 2017, v.8 no.44, 77121-77136
- N-6-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation JOURNAL OF MEDICINAL CHEMISTRY, 2017, v.60 no.8, 3422-3437
- Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, v.27 no.18, 4383-4388
- t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists BIOORGANIC & MEDICINAL CHEMISTRY, 2017, v.25 no.8, 2451-2462
- 2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists Bioorganic and Medicinal Chemistry, 2016, v.24 no.6, 1231-1240
- A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase SCIENTIFIC REPORTS, 2016, v.6, 22389
- Design, synthesis, and anticancer activity of C8-substituted-4′-thionucleosides as potential HSP90 inhibitors Bioorganic and Medicinal Chemistry, 2016, v.24 no.16, 3418-3428
- Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic template Bioorganic and Medicinal Chemistry Letters, 2016, v.26 no.15, 3603-3607
- Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases MOLECULES, 2016, v.21 no.8
- Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors BIOORGANIC & MEDICINAL CHEMISTRY, 2016, v.24 no.18, 4144-4151
- The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3 BIOORGANIC & MEDICINAL CHEMISTRY, 2016, v.24 no.21, 5036-5046
- Ultraslow Water-Mediated Transmembrane Interactions Regulate the Activation of A(2A) Adenosine Receptor BIOPHYSICAL JOURNAL, 2016, v.111 no.6, 1180-1191
- 5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression Bioorganic and Medicinal Chemistry, 2015, v.23 no.21, 7069-7078
- 6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists Bioorganic and Medicinal Chemistry Letters, 2015, v.25 no.4
- Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling EXPERIMENTAL DERMATOLOGY, 2015, v.24 no.7, 503-509
- Communication over the Network of Binary Switches Regulates the Activation of A(2A) Adenosine Receptor PLOS COMPUTATIONAL BIOLOGY, 2015, v.11 no.2
- Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications Advances in Protein Chemistry and Structural Biology, 2015, 4 JAN 2016
- Role of computer-aided drug design in modern drug discovery Archives of Pharmacal Research, 2015, 25 JUL 2015
- Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists Bioorganic and Medicinal Chemistry, 2015, v.23 no.21, 6844-6854
- Structure-Activity Relationships of Neplanocin A Analogues as S -Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities Journal of Medicinal Chemistry, 2015, v.58 no.12, 5108-5120
- The cell shape-determining Csd6 protein from Helicobacter pylori constitutes a new family of L, D-carboxypeptidase Journal of Biological Chemistry, 2015, v.290 no.41, 25103-25117
- Total synthesis of the putative structure of the proposed Banyasin A Frontiers in Chemistry, 2015, v.3
- Transient receptor potential vanilloid type 1 antagonists: a patent review (2011-2014) EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, v.25 no.3, 291-318
- alpha-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, v.25 no.11, 2326-2330
- 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists Bioorganic and Medicinal Chemistry Letters, 2014, v.24 no.16
- 2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4- methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists Bioorganic and Medicinal Chemistry Letters, 2014, v.24 no.16, 4044-4047
- Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, v.24 no.1, 382-385
- Mapping the intramolecular signal transduction of G-protein coupled receptors PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2014, v.82 no.5, 727-743
- Promiscuous gating modifiers target the voltage sensor of Kv7.2, TRPV1, and Hv1 cation channels FASEB Journal, 2014, v.28 no.6, 2591-2602
- Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, v.449 no.4, 399-404
- Synthesis and Anti-Renal Fibrosis Activity of Conformationally Locked Truncated 2-Hexynyl-N-6-Substituted-(N)-Methanocarba-nucleosides as A(3) Adenosine Receptor Antagonists and Partial Agonists JOURNAL OF MEDICINAL CHEMISTRY, 2014, v.57 no.4, 1344-1354
- [학술지논문] Advances in Molecular Dynamics Simulations and Enhanced Sampling Methods for the Study of Protein Systems INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.17 , 6339-6359
- [학술지논문] Asymmetric Total Syntheses of Kopsane Alkaloids via a PtCl2-Catalyzed Intramolecular [3+2] Cycloaddition ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, v.59 no.31 , 12832-12836
- [학술지논문] Multiscale Molecular Modeling in G Protein-Coupled Receptor (GPCR)-Ligand Studies BIOMOLECULES, 2020, v.10 no.4 , 631-643
- [학술지논문] Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design JOURNAL OF MEDICINAL CHEMISTRY, 2019, v.62 no.17 , 8011-8027
- [학술지논문] In Vivo Albumin Traps Photosensitizer Monomers from Self-Assembled Phthalocyanine Nanovesicles: A Facile and Switchable Theranostic Approach JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, v.141 no.3 , 1366-1372
- [학술지논문] Total Synthesis of Hoiamide A Using an Evans-Tishchenko Reaction as a Key Step ORGANIC LETTERS, 2019, v.21 no.14 , 5471-5474
- [학술지논문] Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 Signaling CELL METABOLISM, 2019, v.29 no.6 , 1306-1306
- [학술지논문] Water-Soluble Phthalocyanines Selectively Bind to Albumin Dimers: A Green Approach Toward Enhancing Tumor-Targeted Photodynamic Therapy THERANOSTICS, 2019, v.9 no.22 , 6412-6423
- [학술발표] Introduction of My Career Path as a Scienctist in the Interdisciplinary and International Research KWSE Smart Sister Program, 대한민국, 2020-10-24 KWSE Smart Sister Program, 2020
- [학술발표] Molecular Modeling and Computer-Aided Drug Design (CADD), and their Applications to Drug Discovery 숭실대학교 생명정보학과 세미나, 대한민국, 2020-10-15 숭실대학교 생명정보학과 세미나, 2020
- [학술발표] Molecular Modeling and Computer-Aided Drug Design (CADD), and their Applications to Drug Discovery 전남대학교 약학대학 초청세미나, 대한민국, 2020-01-08 전남대학교 약학대학 초청세미나, 2020
- [학술발표] Application of Artificial Intelligence (AI) and Big Data for Computer-Aided Drug Design (CADD) to Enhance Drug Discovery 제6회 아주대학교 의·약학 공동 심포지엄, 대한민국, 2019-11-28 제6회 아주대학교 의·약학 공동 심포지엄, 2019
- [학술발표] Comprehensive mechanistic studies of a tetraspanin arginine sensor for the elucidation of mode of action and fibrosis inhibitor discovery 2019 MRC 성과발표회, 대한민국, 2019-12-10 2019 MRC 성과발표회, 2019
- [학술발표] Molecular Modeling and Computer-Aided Drug Design (CADD), and their Applications to Drug Discovery KAIST 화학과 세미나, 대한민국, 2019-11-27 KAIST 화학과 세미나, 2019
- [학술발표] Molecular Modeling and Computer-Aided Drug Design (CADD), and their Applications to Drug Discovery ACBI 2019 Jakarta Tutorial & Interview, 인도네시아, 2019-12-07 ACBI 2019 Jakarta Tutorial & Interview, 2019
- [학술발표] 슈퍼컴퓨터를 활용한 단백질 3차원 구조 및 메커니즘 연구와 신약개발에의 응용 KISTI 슈퍼컴데이, 대한민국, 2019-12-03 KISTI 슈퍼컴데이, 2019
강의
-
2023-2학기
-
의약화학Ⅱ 강의 계획서 상세보기
- 학수번호 36210분반 01
- 5학년 ( 3학점 , 3시간) 화 5~5 (약A400) , 목 5~5 (약A400)
- 전공필수 학번 1~43
-
의약화학Ⅱ 강의 계획서 상세보기
- 학수번호 36210분반 02
- 5학년 ( 3학점 , 3시간) 수 5~5 (약A400) , 금 5~5 (약A400)
- 전공필수 학번 44~86
-
의약화학Ⅱ 강의 계획서 상세보기
- 학수번호 36210분반 03
- 5학년 ( 3학점 , 3시간) 수 3~3 (약A400) , 금 3~3 (약A400)
- 전공필수 학번 87~130, 산업제약학과 04반과 합반
-
의약화학Ⅱ 강의 계획서 상세보기
- 학수번호 36210분반 04
- 5학년 ( 3학점 , 3시간) 수 3~3 (약A400) , 금 3~3 (약A400)
- 전공필수 약학과 03반과 합반
-
약학실습Ⅳ 강의 계획서 상세보기
- 학수번호 37127분반 01
- 4학년 ( 1.5학점 , 3시간) 월 6~7 (약A309)
- 전공필수 학번 1-20
-
약학실습Ⅳ 강의 계획서 상세보기
- 학수번호 37127분반 02
- 4학년 ( 1.5학점 , 3시간) 화 6~7 (약A309)
- 전공필수 학번 21~40
-
약학실습Ⅳ 강의 계획서 상세보기
- 학수번호 37127분반 03
- 4학년 ( 1.5학점 , 3시간) 수 6~7 (약A309)
- 전공필수 학번 41-60
-
-
2023-1학기
-
약물유기작용메커니즘
- 학수번호 22574분반 01
- 4학년 ( 1.5학점 , 1.5시간) 월 3~3 (약A400)
- 영어강의 학번 1~60
-
약물유기작용메커니즘
- 학수번호 22574분반 02
- 4학년 ( 1.5학점 , 1.5시간) 수 3~3 (약A400)
- 영어강의 학번 61~120
-
의약화학Ⅰ 강의 계획서 상세보기
- 학수번호 36202분반 01
- 5학년 ( 3학점 , 3시간) 화 4~4 (약A400) , 목 3~3 (약A400)
- 전공필수 학번 1~43
-
의약화학Ⅰ 강의 계획서 상세보기
- 학수번호 36202분반 02
- 5학년 ( 3학점 , 3시간) 화 3~3 (약A400) , 목 6~6 (약A400)
- 전공필수 학번 44~86
-
의약화학Ⅰ 강의 계획서 상세보기
- 학수번호 36202분반 03
- 5학년 ( 3학점 , 3시간) 수 5~5 (약A400) , 금 6~6 (약A404)
- 전공필수 학번 87~130. 산업제약학과 04반과 합반
-
의약화학Ⅰ 강의 계획서 상세보기
- 학수번호 36202분반 04
- 5학년 ( 3학점 , 3시간) 수 5~5 (약A400) , 금 6~6 (약A404)
- 전공필수 약학과 03반과 합반
-
약학실습Ⅳ 강의 계획서 상세보기
- 학수번호 37127분반 01
- 4학년 ( 1.5학점 , 3시간) 월 6~7 (약A309)
- 전공필수 학번 61~80
-
약학실습Ⅳ 강의 계획서 상세보기
- 학수번호 37127분반 02
- 4학년 ( 1.5학점 , 3시간) 화 6~7 (약A309)
- 전공필수 학번 81~100
-
약학실습Ⅳ 강의 계획서 상세보기
- 학수번호 37127분반 03
- 4학년 ( 1.5학점 , 3시간) 수 6~7 (약A309)
- 전공필수 학번 101~120
-
약학연구입문 강의 계획서 상세보기
- 학수번호 38940분반 01
- 2학년 ( 1.5학점 , 1.5시간) 목 6~6 (약A404)
- 전공필수
-
신약개발을위한분자모델링
- 학수번호 G16852분반 01
- 학년 ( 3학점 , 3시간) 금 2~3 (약A204)
- 영어강의
-
-
2022-2학기
-
의약화학Ⅱ
- 학수번호 36210분반 01
- 5학년 ( 3학점 , 3시간) 화 5~5 (약A104) , 목 4~4 (약A104)
- 전공필수 팀티칭, 학번 1~43
-
의약화학Ⅱ
- 학수번호 36210분반 02
- 5학년 ( 3학점 , 3시간) 수 5~5 (약A104) , 금 5~5 (약A400)
- 전공필수 팀티칭, 학번 44~86
-
의약화학Ⅱ
- 학수번호 36210분반 03
- 5학년 ( 3학점 , 3시간) 수 3~3 (약A400) , 금 4~4 (약A400)
- 전공필수 팀티칭, 학번 87~130, 산업제약학과 04반과 합반
-
의약화학Ⅱ
- 학수번호 36210분반 04
- 5학년 ( 3학점 , 3시간) 수 3~3 (약A400) , 금 4~4 (약A400)
- 전공필수 약학과 03반과 합반
-
약학실습Ⅳ
- 학수번호 37127분반 01
- 4학년 ( 1.5학점 , 3시간) 월 6~7 (약A309)
- 전공필수 팀티칭,학번 1~22
-
약학실습Ⅳ
- 학수번호 37127분반 02
- 4학년 ( 1.5학점 , 3시간) 화 6~7 (약A309)
- 전공필수 팀티칭,학번 23~43
-
약학실습Ⅳ
- 학수번호 37127분반 03
- 4학년 ( 1.5학점 , 3시간) 수 6~7 (약A309)
- 전공필수 팀티칭,학번 44~65
-
약물디자인
- 학수번호 G16894분반 01
- 학년 ( 3학점 , 3시간) 화 2~3 (약A204)
- 강의실변경,영어강의
-
-
2021-1학기
-
약물유기작용메커니즘
- 학수번호 22574분반 01
- 4학년 ( 1.5학점 , 1.5시간) 화 3~3
- 영어강의 학번 1~65
-
약물유기작용메커니즘
- 학수번호 22574분반 02
- 4학년 ( 1.5학점 , 1.5시간) 수 2~2
- 영어강의 학번 66~130(산업제약학과03반과 합반)
-
약물유기작용메커니즘
- 학수번호 22574분반 03
- 4학년 ( 1.5학점 , 1.5시간) 수 2~2
- 영어강의 약학과02반과 합반
-
의약화학Ⅰ
- 학수번호 36202분반 01
- 5학년 ( 3학점 , 3시간) 월 5~5 , 수 5~5
- 전공필수 팀티칭/ 학번 1~43
-
의약화학Ⅰ
- 학수번호 36202분반 02
- 5학년 ( 3학점 , 3시간) 화 5~5 , 목 5~5
- 전공필수 팀티칭/ 학번 44~86
-
의약화학Ⅰ
- 학수번호 36202분반 03
- 5학년 ( 3학점 , 3시간) 월 3~3 , 목 3~3
- 전공필수 팀티칭/ 학번 87~130
-
약학실습Ⅳ
- 학수번호 37127분반 01
- 4학년 ( 1.5학점 , 3시간) 월 6~7 (약A309)
- 전공필수 팀티칭/ 학번 66~86
-
약학실습Ⅳ
- 학수번호 37127분반 02
- 4학년 ( 1.5학점 , 3시간) 화 6~7 (약A309)
- 전공필수 팀티칭/ 학번 87~108
-
약학실습Ⅳ
- 학수번호 37127분반 03
- 4학년 ( 1.5학점 , 3시간) 수 6~7 (약A309)
- 전공필수 팀티칭/ 학번109~130(산업제약학과 04반과 합반)
-
약학실습Ⅳ
- 학수번호 37127분반 04
- 4학년 ( 1.5학점 , 3시간) 수 6~7 (약A309)
- 전공필수 팀티칭(약학과03반과 합반)
-
신약개발을위한분자모델링
- 학수번호 G16852분반 01
- 학년 ( 3학점 , 3시간) 금 5~6 (약)
- 영어강의
-
학력
State University of New York at Buffalo Ph.D.(Medicinal Chemistry)
이화여자대학교 약학사(제약학과)